TrademarkDir
PHAGE PHARMACEUTICALS, INC.
DEAD

Serial Number

85066076

Owner

Phage Pharmaceuticals, Inc.

Attorney

F. Richard Rimer, Jr., Esq.

First Use Date

Apr 27, 2011

Filing Date

Jun 18, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PHAGE PHARMACEUTICALS, INC. Trademark

Serial Number: 85066076 • Registration: 4054806

PHAGE PHARMACEUTICALS, INC. is a trademark filed by Phage Pharmaceuticals, Inc. on June 18, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Phage Pharmaceuticals, Inc. (2 trademarks)

6868 Nancy Ridge Drive, Suite 100
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

June 18, 2010

Registration Date

November 15, 2011

First Use Anywhere

April 27, 2011

First Use in Commerce

April 27, 2011

Published for Opposition

August 30, 2011

Cancellation Date

June 22, 2018

Goods & Services

Pharmaceutical preparations, namely, therapeutic proteins for the prevention and treatment of human diseases

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 22, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 15, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 15, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2011 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 27, 2011 PREV
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jul 26, 2011 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 25, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 25, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 25, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 25, 2011 CNEA
USE AMENDMENT ACCEPTED
Jul 25, 2011 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 14, 2011 ERFR
AMENDMENT TO USE PROCESSING COMPLETE
Jul 14, 2011 AUPC
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 11, 2011 GNFN
FINAL REFUSAL E-MAILED
Jul 11, 2011 GNFR
FINAL REFUSAL WRITTEN
Jul 11, 2011 CNFR
AMENDMENT FROM APPLICANT ENTERED
Jun 8, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2011 CRFA
USE AMENDMENT FILED
Jun 6, 2011 IUAF
PAPER RECEIVED
Jun 6, 2011 MAIL
NOTIFICATION OF PRIORITY ACTION E-MAILED
Dec 6, 2010 GPRN
PRIORITY ACTION E-MAILED
Dec 6, 2010 GPRA
PRIORITY ACTION WRITTEN
Dec 6, 2010 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 9, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 29, 2010 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 21, 2010 PREV
ASSIGNED TO LIE
Oct 21, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 30, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 30, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 30, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jun 23, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2010 NWOS
NEW APPLICATION ENTERED
Jun 22, 2010 NWAP

Related Trademarks

More from this Owner

PHAGE PHARMACEUTICALS, INC. logo

PHAGE PHARMACEUTICALS, INC.

PHAGE PHARMACEUTICALS, INC. logo

PHAGE PHARMACEUTICALS, INC.

PHAGE PHARMACEUTICALS, INC. logo

PHAGE PHARMACEUTICALS, INC.